BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2877699)

  • 21. The in-vivo cardiovascular effects of a putative class III anti-arrhythmic drug, AM 92016.
    Hagerty MJ; Wainwright CL; Kane KA
    J Pharm Pharmacol; 1996 Apr; 48(4):417-21. PubMed ID: 8794994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pretreatment with phenytoin, lidocaine and quinidine on the cardiodynamic and electrophysiological effects of ouabain in the cat heart-lung preparation.
    Simaan JA
    Arch Int Pharmacodyn Ther; 1993; 324():47-59. PubMed ID: 8297185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs.
    Kaschube M; Brasch H
    Cardiovasc Res; 1991 Mar; 25(3):230-4. PubMed ID: 2029712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective action of cimetidine against ouabain-induced pressor effects, arrhythmias, and lethality in guinea pigs.
    Trzeciakowski JP
    J Cardiovasc Pharmacol; 1985; 7(4):622-9. PubMed ID: 2410699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma CPU-86017 concentrations regarding suppression of ouabain-induced cardiac arrhythmias and decrease of heart rate in guinea pigs.
    Khan HH; Dai DZ; Xiao DW; Lin S; Wang ZZ; Lou S; Qing Q
    Acta Pharmacol Sin; 2000 Nov; 21(11):1039-42. PubMed ID: 11501061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the 7-oxo-PgI2 induced lasting protection against ouabain arrhythmias in anesthetized guinea pigs.
    Szilvássy Z; Szekeres L; Udvary E; Végh A
    Biomed Biochim Acta; 1988; 47(10-11):S35-8. PubMed ID: 2470357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier-mediated norepinephrine release and reperfusion arrhythmias induced by protracted ischemia in isolated perfused guinea pig hearts: effect of presynaptic modulation by alpha(2)-adrenoceptor in mild hypothermic ischemia.
    Oka J; Imamura M; Hatta E; Maruyama R; Isaka M; Murashita T; Yasuda K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):681-7. PubMed ID: 12388651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of dextromethorphan and tizanidine on ouabain-induced arrhythmias.
    Uresin Y; Ozek M; Sevgi S
    Methods Find Exp Clin Pharmacol; 2002 Sep; 24(7):421-3. PubMed ID: 12428430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adrenergic beta-blockers and a membrane stabilizing agent on ouabain-induced cardiac arrhythmias in anaesthetized guinea pigs.
    Aberg G; Adler G; Duker G; Ek B; Telemo E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):102-6. PubMed ID: 40389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
    Mundey MK; Mason R; Wilson VG
    Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of delayed afterdepolarisations by alpha 1 adrenergic receptor subtypes.
    Lee JH; Rosen MR
    Cardiovasc Res; 1993 May; 27(5):839-44. PubMed ID: 8102323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain.
    Wang YX; Tan YH; Sheng BH
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):226-30. PubMed ID: 1442104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of clonidine pre-treatment on bupivacaine and ropivacaine cardiotoxicity in rats.
    Gulec S; Aydin Y; Uzuner K; Yelken B; Senturk Y
    Eur J Anaesthesiol; 2004 Mar; 21(3):205-9. PubMed ID: 15055893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of verapamil upon ouabain-induced cardiac arrhythmias.
    Khatter JC; Navaratnam S; Hoeschen RJ
    Pharmacology; 1988; 36(6):380-9. PubMed ID: 3420160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ouabain attenuates cardiotoxicity induced by other cardiac steroids.
    Nesher M; Shpolansky U; Viola N; Dvela M; Buzaglo N; Cohen Ben-Ami H; Rosen H; Lichtstein D
    Br J Pharmacol; 2010 May; 160(2):346-54. PubMed ID: 20423344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmias and alpha 1-adrenoceptor binding characteristics of the guinea-pig perfused heart during ischaemia and reperfusion.
    Chess-Williams RG; Sheridan DJ; Broadley KJ
    J Mol Cell Cardiol; 1990 May; 22(5):599-606. PubMed ID: 1974933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-adrenoceptor modulation of the efferent function of capsaicin-sensitive sensory neurones in guinea-pig isolated atria.
    Amerini S; Rubino A; Mantelli L; Ledda F
    Br J Pharmacol; 1992 Apr; 105(4):947-53. PubMed ID: 1354538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.